Some reports suggest that in the presence of EGFR ligand secreted by tumor cells, CD3+CD8+CD69+Ki67+ T-lymphocytes produce more IFN-γ and TNF-α and show a stronger antitumor response [27]. The gene discussed is CD8A; the disease is neoplasm.